Earnings Feed
Start Free
Home/Filings/4/0001298900-12-000006
4//SEC Filing

Titus Gary 4

Accession 0001298900-12-000006

CIK 0000880771other
View on SEC.govCompany Profile

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 4:58 PM ET

Size

19.6 KB

Accession

0001298900-12-000006

Insider Transaction Report

Form 4
Period: 2012-05-31
SCICLONE PHARMACEUTICALS INCSCLN
Titus Gary
Senior VP Finance & CFO
Transactions
  • Sale

    Common Stock

    2012-06-14$7.05/sh−15,029$105,954→ 37,095 total
  • Exercise/Conversion

    Common Stock

    2012-06-15$0.95/sh+36,954$35,106→ 74,049 total
  • Purchase

    Common Stock

    2012-05-31$3.84/sh+261$1,003→ 37,095 total
  • Exercise/Conversion

    Common Stock

    2012-06-14$0.95/sh+15,029$14,278→ 52,124 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2012-06-15−36,954→ 98,017 total
    Exercise: $0.95Exp: 2018-12-16→ Common Stock (36,954 underlying)
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2012-06-15−29,624→ 68,393 total
    Exercise: $0.95Exp: 2018-12-16→ Common Stock (29,624 underlying)
  • Exercise/Conversion

    Common Stock

    2012-06-15$0.95/sh+29,624$28,143→ 66,719 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2012-06-14−15,029→ 134,971 total
    Exercise: $0.95Exp: 2018-12-16→ Common Stock (15,029 underlying)
  • Sale

    Common Stock

    2012-06-15$6.99/sh−36,954$258,308→ 37,095 total
  • Sale

    Common Stock

    2012-06-15$6.99/sh−29,624$207,072→ 37,095 total
Footnotes (4)
  • [F1]Purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2012.
  • [F2]Granted under the Issuer's 2005 Equity Incentive Plan.
  • [F3]25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
  • [F4]Provided Reporting Person remains employed by the Issuer, the Option will vest based on the achievement of certain performance targets on or prior to December 31, 2010, with 25,000 shares respectively vesting upon attainment of each of three specified goals. If these targets are not achieved on or before December 31, 2010, the Option will not vest and will terminate at that time.

Documents

1 file

Issuer

SCICLONE PHARMACEUTICALS INC

CIK 0000880771

→
Entity typeother

Related Parties

1
  • filerCIK 0001298900

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:58 PM ET
Size
19.6 KB
View on SEC.gov